SPECIFICATION OF ANALYTICAL REQUIREMENT

2005 ◽  
pp. 145-145
Keyword(s):  
Analytical Requirement

scholarly journals How to meet ISO15189:2012 pre-analytical requirements in clinical laboratories? A consensus document by the EFLM WG-PRE

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Pieter Vermeersch ◽  
Glynis Frans ◽  
Alexander von Meyer ◽  
Seán Costelloe ◽  
Giuseppe Lippi ◽  
...  
Keyword(s):  
Quality Management System ◽  
Clinical Chemistry ◽  
European Federation ◽  
Consensus Recommendation ◽  
Iso 15189 ◽  
Consensus Document ◽  
Analytical Phase ◽  
Total Testing Process ◽  
Analytical Requirements ◽  
Analytical Requirement

Abstract The International Organization for Standardization (ISO) 15189:2012 standard aims to improve quality in medical laboratories through standardization of all key elements in the total testing process, including the pre-analytical phase. It is hence essential that accreditation bodies, assessing laboratories against ISO15189:2012, pay sufficient attention to auditing pre-analytical activities. However, there are significant differences in how technical auditors interpret the pre-analytical requirements described in ISO15189:2012. In this consensus document, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Pre-analytical Phase (WG-PRE) sets out to review pre-analytical requirements contained in ISO15189:2012 and provide guidance for laboratories on how to meet these requirements. The target audience for this consensus document is laboratory professionals who wish to improve the quality of the pre-analytical phase in their laboratory. For each of the ISO requirements described in ISO15189:2012, members of EFLM WG-PRE agreed by consensus on minimal recommendations and best-in-class solutions. The minimal consensus recommendation was defined as the minimal specification which laboratories should implement in their quality management system to adequately address the pre-analytical requirement described in ISO15189:2012. The best-in-class solution describes the current state-of-the-art in fulfilling a particular pre-analytical requirement in ISO15189:2012. We fully acknowledge that not every laboratory has the means to implement these best-in-class solutions, but we hope to challenge laboratories in critically evaluating and improving their current procedures by providing this expanded guidance.

Cholesterol operational process specifications for assuring the quality required by CLIA proficiency testing

1991 ◽  
Vol 37 (11) ◽  
pp. 1938-1944 ◽  
Author(s):  
J O Westgard ◽  
D A Wiebe
Keyword(s):  
Proficiency Testing ◽  
Clinical Laboratory ◽  
Total Error ◽  
Health Care Financing ◽  
Clinical Decision ◽  
Performance Criterion ◽  
Control Procedure ◽  
Interval Model ◽  
Cholesterol Testing ◽  
Analytical Requirement

Abstract Current U.S. governmental regulations and requirements for the quality of laboratory tests do not provide a consistent form, comparable numbers, or practical specifications for the routine operation of laboratory testing processes. For cholesterol, as an example, the Health Care Financing Administration provides an analytical performance criterion for proficiency testing to enforce the Clinical Laboratory Improvement Act (CLIA), whereas the U.S. National Cholesterol Education Program (NCEP) provides clinical guidelines for test interpretation, as well as analytical goals for imprecision and inaccuracy. Routine operating process specifications for imprecision, inaccuracy, and quality control can be derived from the analytical and clinical requirements for quality. Use of an analytical "total error" model and a clinical "decision interval" model provides logically consistent and numerically comparable specifications. Studies with these coherent models indicate that a cholesterol testing process properly planned to satisfy the CLIA analytical requirement will also satisfy the NCEP clinical requirement. To provide 90% assurance of detecting systematic shifts of a magnitude that would cause the CLIA analytical requirement to be exceeded, the operational specifications for a cholesterol testing process are an allowable CV of less than or equal to 2%, an allowable bias of less than or equal to 1%, and a control procedure with two measurements per run interpreted by 1(3)s, 1(2.5)s, or 1(3)s/2(2)s/R4s control rules.

Comparison Study on Measuring Ammonia and Nitrogen in Surface Water by Flow Injection and Nessler's Reagent

2014 ◽  
Vol 884-885 ◽  
pp. 46-50 ◽  
Author(s):  
Yong Gang Zeng ◽  
Lin Chen ◽  
Hai Xia Li ◽  
Jin Huang ◽  
Bo Yu
Keyword(s):  
Detection Limit ◽  
Surface Water ◽  
Flow Injection ◽  
Future Development ◽  
Development Trend ◽  
Comparison Study ◽  
Analysis Method ◽  
Detection Range ◽  
Precision And Accuracy ◽  
Analytical Requirement

This paper compared the measurement of ammonia and nitrogen in surface water by spectrophotometry and flow injection analysis, and the results indicate: Nessler method detection range of 0.02~2.0 mg/L, and detection limit is 0.02mg/L; flow injection detection range 0.01~ 10mg/L, and the detection limit is 0.001mg/L, 50 samples analyzed rate is 50 samples/h; flow injection is simple and in good linearity, and the sensitivity, precision and accuracy can meet the analytical requirement with better analysis speed, low consumption of reagents and samples, which is a sensitive, selective and friendly analysis method, which will be the future development trend.

Sign in / Sign up

Export Citation Format

Share Document